186 related articles for article (PubMed ID: 29095139)
1. Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts.
Pedranti MS; Rodriguez-Lombardi G; Bracciaforte R; Romano N; Lujan P; Ricchi B; Mautino J; Adamo MP
J Med Microbiol; 2017 Dec; 66(12):1715-1721. PubMed ID: 29095139
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic study of human parvovirus B19 infection in East China.
Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
6. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
Weseslindtner L; Aberle JH; Hedman L; Hedman K
J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
8. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
10. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 seroconversion in a cohort of human immunodeficiency virus-infected patients.
Azevedo KM; Setúbal S; Camacho LA; Garcia Rde C; Siqueira MM; Pereira RF; de Oliveira SA
Mem Inst Oswaldo Cruz; 2012 May; 107(3):356-61. PubMed ID: 22510831
[TBL] [Abstract][Full Text] [Related]
13. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
[TBL] [Abstract][Full Text] [Related]
14. Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women.
Gasim GI; Eltayeb R; Elhassan EM; Haggaz AD; Rayis DA; Adam I
Int J Gynaecol Obstet; 2016 Mar; 132(3):318-20. PubMed ID: 26674318
[TBL] [Abstract][Full Text] [Related]
15. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
16. Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series.
Mendes-de-Almeida DP; Bokel JPB; Alves ADR; Vizzoni AG; Tavares ICF; Silva MST; Netto JDSB; Grinsztejn BGJ; Amado Leon LA
Viruses; 2023 May; 15(5):. PubMed ID: 37243210
[TBL] [Abstract][Full Text] [Related]
17. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
Maple PA; Hedman L; Dhanilall P; Kantola K; Nurmi V; Söderlund-Venermo M; Brown KE; Hedman K
J Clin Microbiol; 2014 Mar; 52(3):947-56. PubMed ID: 24403307
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: A multicenter study.
Alves ADR; Langella BB; Barbosa JR; Lima DM; Colares JKB; Garcia RCNC; Pinto MA; Villar LM; Amado LA
Int J Infect Dis; 2020 Nov; 100():350-356. PubMed ID: 32927082
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]